210 Users Online
A Detailed Analysis of the Therapeutic Apheresis Market Based on the Escalating Prevalence of Autoimmune and Hematologic Disorders, and an Increasing Emphasis on Personalized Medicine Approaches
1. Executive Summary
1.1. Global Therapeutic Apheresis Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Procedure Types Lifecycle Analysis
2.4. Therapeutic Apheresis Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Therapeutic Apheresis Market Outlook: Procedure Types
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Procedure Types, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
3.3.3.1. Therapeutic Plasma Exchange (TPE)
3.3.3.2. Red Blood Cell Exchange (RBCX)
3.3.3.3. Cellular Depletions
3.4. Market Attractiveness Analysis: Procedure Types
3.5. Global Therapeutic Apheresis Market Outlook: Technology
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technology, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
3.5.3.1. Centrifugation
3.5.3.2. Membrane filtration
3.6. Market Attractiveness Analysis: Technology
3.7. Global Therapeutic Apheresis Market Outlook: Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.7.3.1. Hematology
3.7.3.2. Neurology
3.7.3.3. Nephrology
3.7.3.4. Rheumatology
3.7.3.5. Oncology
3.7.3.6. Others
3.8. Market Attractiveness Analysis: Application
3.9. Global Therapeutic Apheresis Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. Hospitals
3.9.3.2. Blood banks
3.9.3.3. Specialty clinics
3.10. Market Attractiveness Analysis: End User
4. Global Therapeutic Apheresis Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Procedure Types
5.3.3. By Technology
5.3.4. By Application
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
5.5.1. Therapeutic Plasma Exchange (TPE)
5.5.2. Red Blood Cell Exchange (RBCX)
5.5.3. Cellular Depletions
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
5.6.1. Centrifugation
5.6.2. Membrane filtration
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.7.1. Hematology
5.7.2. Neurology
5.7.3. Nephrology
5.7.4. Rheumatology
5.7.5. Oncology
5.7.6. Others
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. Hospitals
5.8.2. Blood banks
5.8.3. Specialty clinics
5.9. Market Attractiveness Analysis
6. Europe Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Procedure Types
6.3.3. By Technology
6.3.4. By Application
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
6.5.1. Therapeutic Plasma Exchange (TPE)
6.5.2. Red Blood Cell Exchange (RBCX)
6.5.3. Cellular Depletions
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
6.6.1. Centrifugation
6.6.2. Membrane filtration
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.7.1. Hematology
6.7.2. Neurology
6.7.3. Nephrology
6.7.4. Rheumatology
6.7.5. Oncology
6.7.6. Others
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. Hospitals
6.8.2. Blood banks
6.8.3. Specialty clinics
6.9. Market Attractiveness Analysis
7. East Asia Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Procedure Types
7.3.3. By Technology
7.3.4. By Application
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
7.5.1. Therapeutic Plasma Exchange (TPE)
7.5.2. Red Blood Cell Exchange (RBCX)
7.5.3. Cellular Depletions
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
7.6.1. Centrifugation
7.6.2. Membrane filtration
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.7.1. Hematology
7.7.2. Neurology
7.7.3. Nephrology
7.7.4. Rheumatology
7.7.5. Oncology
7.7.6. Others
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. Hospitals
7.8.2. Blood banks
7.8.3. Specialty clinics
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Procedure Types
8.3.3. By Technology
8.3.4. By Application
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
8.5.1. Therapeutic Plasma Exchange (TPE)
8.5.2. Red Blood Cell Exchange (RBCX)
8.5.3. Cellular Depletions
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
8.6.1. Centrifugation
8.6.2. Membrane filtration
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.7.1. Hematology
8.7.2. Neurology
8.7.3. Nephrology
8.7.4. Rheumatology
8.7.5. Oncology
8.7.6. Others
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. Hospitals
8.8.2. Blood banks
8.8.3. Specialty clinics
8.9. Market Attractiveness Analysis
9. Latin America Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Procedure Types
9.3.3. By Technology
9.3.4. By Application
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
9.5.1. Therapeutic Plasma Exchange (TPE)
9.5.2. Red Blood Cell Exchange (RBCX)
9.5.3. Cellular Depletions
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
9.6.1. Centrifugation
9.6.2. Membrane filtration
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.7.1. Hematology
9.7.2. Neurology
9.7.3. Nephrology
9.7.4. Rheumatology
9.7.5. Oncology
9.7.6. Others
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. Hospitals
9.8.2. Blood banks
9.8.3. Specialty clinics
9.9. Market Attractiveness Analysis
10. Middle East & Africa Therapeutic Apheresis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Procedure Types
10.3.3. By Technology
10.3.4. By Application
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure Types, 2023 - 2030
10.5.1. Therapeutic Plasma Exchange (TPE)
10.5.2. Red Blood Cell Exchange (RBCX)
10.5.3. Cellular Depletions
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
10.6.1. Centrifugation
10.6.2. Membrane filtration
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.7.1. Hematology
10.7.2. Neurology
10.7.3. Nephrology
10.7.4. Rheumatology
10.7.5. Oncology
10.7.6. Others
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. Hospitals
10.8.2. Blood banks
10.8.3. Specialty clinics
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Procedure Types Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Asahi Kasei Medical Co.
11.3.1.1. Overview
11.3.1.2. Segments and Procedure Types
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Haemonetics Corporation
11.3.2.1. Overview
11.3.2.2. Segments and Procedure Types
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Miltenyi Biotec
11.3.3.1. Overview
11.3.3.2. Segments and Procedure Types
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Cerus Corporation
11.3.4.1. Overview
11.3.4.2. Segments and Procedure Types
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Terumo BCT Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Procedure Types
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Fresenius Kabi USA
11.3.6.1. Overview
11.3.6.2. Segments and Procedure Types
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Terumo Bct
11.3.7.1. Overview
11.3.7.2. Segments and Procedure Types
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. B. Braun Melsungen AG
11.3.8.1. Overview
11.3.8.2. Segments and Procedure Types
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Nikkiso Co. Ltd.
11.3.9.1. Overview
11.3.9.2. Segments and Procedure Types
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Medica S.p.A.
11.3.10.1. Overview
11.3.10.2. Segments and Procedure Types
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Baxter Healthcare Corporation
11.3.11.1. Overview
11.3.11.2. Segments and Procedure Types
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Kawasumi Laboratories Inc.
11.3.12.1. Overview
11.3.12.2. Segments and Procedure Types
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Therakos Incorporation
11.3.13.1. Overview
11.3.13.2. Segments and Procedure Types
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
